Latest Insider Transactions at Unitedhealth Group Inc (UNH)
This section provides a real-time view of insider transactions for Unitedhealth Group Inc (UNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UNITEDHEALTH GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UNITEDHEALTH GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 12
2018
|
Gail R Wilensky |
BUY
Exercise of conversion of derivative security
|
Direct |
5,740
+4.18%
|
$132,020
$23.76 P/Share
|
Sep 07
2018
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
SELL
Open market or private sale
|
Direct |
26,033
-45.94%
|
$7,028,910
$270.65 P/Share
|
Sep 07
2018
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
BUY
Exercise of conversion of derivative security
|
Direct |
38,249
+19.21%
|
$4,283,888
$112.67 P/Share
|
Aug 24
2018
|
D Ellen Wilson Executive Vice President |
SELL
Open market or private sale
|
Direct |
15,393
-23.18%
|
$4,063,752
$264.29 P/Share
|
Aug 24
2018
|
D Ellen Wilson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+21.33%
|
$1,026,000
$57.38 P/Share
|
Aug 15
2018
|
David S Wichmann Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
473
-0.06%
|
$122,980
$260.61 P/Share
|
Aug 08
2018
|
William C Ballard Jr Director |
SELL
Open market or private sale
|
Direct |
10,000
-6.48%
|
$2,580,000
$258.83 P/Share
|
Aug 08
2018
|
William C Ballard Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.08%
|
$260,000
$26.34 P/Share
|
Aug 01
2018
|
Richard T Burke Director |
SELL
Open market or private sale
|
Direct |
15,000
-0.85%
|
$3,810,000
$254.79 P/Share
|
Jul 18
2018
|
Kenneth Irwin Shine Director |
SELL
Open market or private sale
|
Direct |
177
-0.61%
|
$45,135
$255.72 P/Share
|
Jul 18
2018
|
Gail R Wilensky |
SELL
Open market or private sale
|
Direct |
3,090
-4.96%
|
$778,680
$252.1 P/Share
|
Jul 18
2018
|
Gail R Wilensky |
BUY
Exercise of conversion of derivative security
|
Direct |
890
+1.41%
|
$24,030
$27.02 P/Share
|
Jul 17
2018
|
Richard T Burke Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,780
+0.1%
|
$48,060
$27.02 P/Share
|
Jul 02
2018
|
William C Ballard Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.24%
|
-
|
Jul 02
2018
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.01%
|
-
|
Jul 02
2018
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
304
+12.2%
|
-
|
Jul 02
2018
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.54%
|
-
|
Jul 02
2018
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
304
+38.48%
|
-
|
Jul 02
2018
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
177
+19.69%
|
-
|
Jul 02
2018
|
Glenn M Renwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
329
+0.41%
|
-
|
Jul 02
2018
|
Kenneth Irwin Shine Director |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.6%
|
-
|
Jul 02
2018
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.29%
|
-
|
Jun 29
2018
|
Richard T Burke Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.28%
|
$125,000
$25.63 P/Share
|
Jun 29
2018
|
Gail R Wilensky |
SELL
Payment of exercise price or tax liability
|
Direct |
523
-0.85%
|
$128,135
$245.34 P/Share
|
Jun 29
2018
|
Gail R Wilensky |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.49%
|
$125,000
$25.63 P/Share
|
Jun 26
2018
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
178
+0.35%
|
-
|
Jun 26
2018
|
David S Wichmann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
134
+0.02%
|
-
|
Jun 26
2018
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.27%
|
-
|
Jun 26
2018
|
Marianne D Short EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
83
+0.08%
|
-
|
Jun 26
2018
|
D Ellen Wilson Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
74
+0.15%
|
-
|
Jun 26
2018
|
Larry C Renfro Vice Chmn, UHG and CEO, Optum |
BUY
Grant, award, or other acquisition
|
Direct |
111
+0.07%
|
-
|
Jun 26
2018
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
73
+0.1%
|
-
|
Jun 26
2018
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
65
+0.35%
|
-
|
Jun 26
2018
|
William C Ballard Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
82
+0.11%
|
-
|
Jun 26
2018
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
82
+0.0%
|
-
|
Jun 26
2018
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.37%
|
-
|
Jun 26
2018
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
106
+0.32%
|
-
|
Jun 26
2018
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.55%
|
-
|
Jun 26
2018
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.37%
|
-
|
Jun 26
2018
|
Glenn M Renwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
156
+0.2%
|
-
|
Jun 26
2018
|
Kenneth Irwin Shine Director |
BUY
Grant, award, or other acquisition
|
Direct |
105
+0.36%
|
-
|
Jun 26
2018
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
76
+0.13%
|
-
|
Jun 26
2018
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
436
+0.03%
|
-
|
Jun 15
2018
|
Larry C Renfro Vice Chmn, UHG and CEO, Optum |
SELL
Open market or private sale
|
Direct |
19,652
-11.34%
|
$4,991,608
$254.55 P/Share
|
Jun 07
2018
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,159
-1.64%
|
$287,432
$248.98 P/Share
|
Jun 05
2018
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
49,504
+47.04%
|
-
|
May 30
2018
|
Richard T Burke Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,540
+0.09%
|
$50,820
$33.94 P/Share
|
May 21
2018
|
Richard T Burke Director |
SELL
Open market or private sale
|
Direct |
15,000
-0.85%
|
$3,720,000
$248.82 P/Share
|
May 11
2018
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,185
-4.45%
|
$282,030
$238.28 P/Share
|
May 11
2018
|
Thomas E Roos Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,625
+5.75%
|
$180,375
$111.16 P/Share
|